The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.
<h4>Objective</h4>Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism had higher plasma PAI-1 concentrations and higher risk of death than those with the 4G/5G or 5G/5G genotypes; one study involved 175 chi...
Main Authors: | Leonardo Lorente, María M Martín, Juan M Borreguero-León, Ysamar Barrios, Jordi Solé-Violán, José Ferreres, Lorenzo Labarta, César Díaz, Alejandro Jiménez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0129565 |
Similar Items
-
Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
by: Leonardo Lorente, et al.
Published: (2016-11-01) -
The prevalence of PAI-1 4G/5G gene variant in Serbian population
by: Đorđević Valentina, et al.
Published: (2013-01-01) -
The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
by: Maja Živković, et al.
Published: (2014-01-01) -
A rapid detection method for PAI-1 promoter insertion/deletion polymorphism (4G/5G)
by: Annichino-Bizzacchi Joyce M., et al.
Published: (1998-01-01) -
In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time.
by: Zelda de Lange, et al.
Published: (2013-01-01)